INFLIXIMAB CLEARANCE PRE-THERAPY AND DURING INDUCTION PREDICTS LONG TERM DISEASE CONTROL IN INFLAMMATORY BOWEL DISEASE

被引:0
|
作者
Vermeire, Severine
D'Haens, Geert
Laharie, David
Dreesen, Erwin
Rabizadeh, Shervin
Jain, Anjali
Spencer, Elizabeth A.
Panetta, John C.
Dubinsky, Marla
Dervieux, Thierry
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
234
引用
收藏
页码:S45 / S46
页数:2
相关论文
共 50 条
  • [21] Infliximab Therapy in Children and Adolescents with Inflammatory Bowel Disease
    Gabor Veres
    Robert N. Baldassano
    Petar Mamula
    Drugs, 2007, 67 : 1703 - 1723
  • [22] Infliximab therapy in children and adolescents with inflammatory bowel disease
    Veres, Gabor
    Baldassano, Robert N.
    Mamula, Petar
    DRUGS, 2007, 67 (12) : 1703 - 1723
  • [23] Increasing treatment time on REMICADE® (infliximab) predicts subsequent long-term retention in stable infliximab inflammatory bowel disease patients in Canada
    Marshall, J. K.
    Marrache, A. M.
    Ewara, E.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S272 - S273
  • [24] How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel disease?
    Chaparro, Maria
    Gisbert, Javier P.
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (12) : 1749 - 1762
  • [25] Long-Term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease: A Single-Centre Observational Study
    Armuzzi, Alessandro
    Marzo, Manuela
    Felice, Carla
    De Vincentis, Fabio
    Andrisani, Gianluca
    Mocci, Giammarco
    Pugliese, Daniela
    Fedeli, Paolo
    De Vitis, Italo
    Papa, Alfredo
    Gasbarrini, Antonio
    Guidi, Luisa
    GASTROENTEROLOGY, 2010, 138 (05) : S691 - S692
  • [26] Long-term scheduled therapy with infliximab in inflammatory bowel disease: a single-centre observational study
    Felice, C.
    Ferraro, P. M.
    Marzo, M.
    Pugliese, D.
    Papa, A.
    Rapaccini, G. L.
    Guidi, L.
    Armuzzi, A.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S384 - S384
  • [27] Stopping Infliximab During Pregnancy in Inflammatory Bowel Disease
    Truta, Brindusa
    Althumairi, Azah
    Canner, Joseph K.
    Schneider, Eric B.
    Safar, Bashar
    GASTROENTEROLOGY, 2015, 148 (04) : S261 - S261
  • [28] Long-term treatment with infliximab in inflammatory bowel disease: safety and tolerability issues
    Caviglia, Renato
    Boskoski, Ivo
    Cicala, Michele
    EXPERT OPINION ON DRUG SAFETY, 2008, 7 (05) : 617 - 632
  • [29] Long-Term Safety of Infliximab in CVID-Related Inflammatory Bowel Disease
    Verma, N.
    Webster, A. D.
    Seneviratne, S. L.
    Burns, S. O.
    Dziadio, M.
    Symes, A.
    Workman, S.
    Grimbacher, B.
    Chee, R.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S166 - S167
  • [30] Long-term treatment of inflammatory bowel disease associated spondyloarthropathy with infliximab.
    Antivalle, Marco
    Mutti, Alessandra
    Bertani, Luca
    Randisi, Giovanna
    Vulpio, Laura
    Ardizzone, Sandro
    Colombo, Elisabetta
    Carrabba, Mario
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S472 - S472